Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Crohn's DiseaseUlcerative Colitis (UC)Rheumatoid Arthritis (RA)Psoriatic ArthritisPsoriasisAnkylosing Spondylitis (AS)Non-radiographic Axial Spondyloarthritis
Trial Locations (15)

1050-034

Instituto Portugues De Reumatologia /ID# 205963, Lisbon

1169-050

Centro Hosp de Lisboa Central /ID# 205698, Lisbon

1349-019

Centro Hospitalar Lisboa Ocidental, EPE /ID# 201328, Lisbon

Centro Hospitalar Lisboa Ocidental, EPE /ID# 201330, Lisbon

4710-243

CCA Braga - Hospital de Braga /ID# 201322, Braga

CCA Braga - Hospital de Braga /ID# 201323, Braga

CCA Braga - Hospital de Braga /ID# 201324, Braga

1150-069

Hospital Santo Antonio dos Cap /ID# 205700, Lisbon

1649-035

Centro Hospitalar Lisboa Norte, EPE /ID# 201335, Lisbon

Centro Hospitalar Lisboa Norte, EPE /ID# 201336, Lisbon

Centro Hospitalar Lisboa Norte, EPE /ID# 201337, Lisbon

4200-319

Centro Hospitalar de Sao Joao, EPE /ID# 203535, Porto

Centro Hospitalar de Sao Joao, EPE /ID# 206278, Porto

3504 - 509

Centro Hosp de Tondela-Viseu /ID# 203774, Viseu

Centro Hosp de Tondela-Viseu /ID# 203775, Viseu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY